Vastavam web: India is all set to get its first coronavirus vaccine. The Oxford University-AstraZeneca vaccine candidate – Covishield – is completing its trials soon and will be commercialised in 73 days, a top official at Serum India told. Serum Institute of India is handling phase 3 of the trials. The vaccine is developed by Oxford University and is likely to move to production to India. “By this, the first dosing will take place today in the final phase and the second dosing will happen after 29 days. The final trial report will be out in another 15 days from the second dosing. The phase 3 trials began August 22 at 20 centres across the country. The vaccine will be administered to 1,600 people in this phase.